• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 0.32% Nasdaq Down 0.01%

    RXi Pharmaceuticals Corporation (RXII)

    -NasdaqCM
    0.41 Down 0.00(0.24%) Jul 31, 4:00PM EDT
    Add to Portfolio
    Prev Close:0.41
    Open:0.40
    Bid:0.40 x 30000
    Ask:0.47 x 1400
    1y Target Est:3.63
    Beta:1.76
    Next Earnings Date:12-Aug-15RXII Earnings announcement
    Day's Range:0.40 - 0.43
    52wk Range:0.34 - 3.98
    Volume:306,108
    Avg Vol (3m):1,814,620
    Market Cap:23.46M
    P/E (ttm):N/A
    EPS (ttm):-0.63
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for RXII

    Comparison

    Symbol% ChgMkt Cap
    RXIIDown 0.24%23.46M
    AGNUp 0.69%130.10B
    ALNYUp 1.57%10.74B
    MRNADown 6.07%10.00M

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):309.45
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-0.30
    Quarterly EPS Est (Jun-15) :-0.09
    Mean Recommendation*:1.5
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    RXi Pharmaceuticals Corporation, a biotechnology company, focuses on discovering and developing therapies primarily in the areas of dermatology and ophthalmology. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback